首页> 美国卫生研究院文献>Vaccines >Disease Resurgence Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?
【2h】

Disease Resurgence Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?

机译:人口老龄化背景下的疾病复发生产能力问题和安全问题:是否需要新的黄热病疫苗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Yellow fever is a potentially fatal, mosquito-borne viral disease that appears to be experiencing a resurgence in endemic areas in Africa and South America and spreading to non-endemic areas despite an effective vaccine. This trend has increased the level of concern about the disease and the potential for importation to areas in Asia with ecological conditions that can sustain yellow fever virus transmission. In this article, we provide a broad overview of yellow fever burden of disease, natural history, treatment, vaccine, prevention and control initiatives, and vaccine and therapeutic agent development efforts.
机译:黄热病是一种可能致命的,由蚊子传播的病毒性疾病,在非洲和南美洲的流行地区似乎正在重新流行,并且尽管已接种了有效的疫苗,但仍传播到非流行地区。这种趋势增加了人们对该病的关注程度,并增加了向具有可持续维持黄热病病毒传播的生态条件的亚洲地区进口的可能性。在本文中,我们提供了黄热病疾病负担,自然史,治疗,疫苗,预防和控制措施以及疫苗和治疗剂开发工作的广泛概述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号